Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Retained Earnings (2016 - 2017)

Historic Retained Earnings for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $56.4 million.

  • Bone Biologics' Retained Earnings rose 1893.16% to $56.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was $56.4 million, marking a year-over-year increase of 1893.16%. This contributed to the annual value of -$52.1 million for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q3 2017, Bone Biologics' Retained Earnings is $56.4 million, which was up 1893.16% from $54.0 million recorded in Q2 2017.
  • Bone Biologics' Retained Earnings' 5-year high stood at $56.4 million during Q3 2017, with a 5-year trough of -$52.1 million in Q4 2016.